一、交易提示 | | 你 | 基金经理 | 首次蔡集[ | | | | --- | --- | --- | --- | --- | --- | | | | | (477) | | | | 026109 | 广发中证 500 指数量化增强 A | 李肯意 | 80.00 | 股票配 | 2026-02-09 | | 026110 | 广发中证 500 指数量化增强 C | 李肯懿 | 80.00 | Bonner | 2026-02-09 | | 026223 | 广发消费领航股票 A | 孙迪 | 80.00 | Bo Bear Par | 2026-02-03 | | 026224 | 广发消费领航股票 C | 孙迪 | 80.00 | 股票型 | 2026-02-03 | | 026066 | 易方达成长驱动混合 A | 何一钱,姚欢宸 | 20.00 | 温合型 | 2026-02-10 | | 026067 | 易方达成长驱动混合 C | 何一钱姚欢宸 | 20.00 | 混合型 | 2026-02-10 | | 026462 | 景顺长城均衡增长股票 | 壬肝展 | 未公布 | 股票型 | 2026 ...

2026年1月以来，公募基金调研活动持续升温，科技成长板块成为核心布局方向，AI应用、商业航天、 创新药及半导体等领域的上市公司获得重点关注。其中，大金重工、翔宇医疗、海天瑞声、爱朋医疗、 熵基科技、美好医疗、博拓生物、天承科技、三七互娱、航天宏图等多家企业均获超百家机构调研。多 位基金经理密集调研细分赛道龙头企业，聚焦技术壁垒高、场景落地明确的优质标的，清晰反映出机构 对科技领域"技术突破+业绩兑现"的双重重视。 ...

每经记者｜杨建 每经编辑｜彭水萍 （一）重要市场新闻 点评：量子计算是遵循量子力学规律来操控信息单元的一种全新计算模式。作为下一代信息技术的核心 驱动力，量子计算能够有效解决传统计算算力不足的难题，被视作引领下一代产业变革的颠覆性技术， 也成为全球科技竞争的战略焦点。技术突破、政策支持与市场需求共同驱动产业快速发展，其应用场景 从专用计算向通用计算拓展，推动金融、医药、能源等领域深度变革。量子计算产业正处于"技术驱动 向应用牵引"的关键转折期，2025-2030年将是商业化落地的黄金窗口，有望迈进千亿美元市场规模。概 念股包括科大国创、迪普科技、国盾量子等。 1、美股三大指数收盘涨跌不一，道指跌0.83%，纳指涨0.91%，标普500指数涨0.41%；科技股普涨，英 特尔涨超3%，亚马逊涨超2%。医疗保险股普跌，标普1500管理型医疗指数下跌18%，创下自1997年以 来的最大跌幅；联合健康跌超19%，CVS跌超14%。中概股涨跌不一，纳斯达克中国金龙指数涨 0.48%，爱奇艺、哔哩哔哩涨超3%，携程集团跌逾2%，小鹏汽车、理想汽车跌超1%。欧洲主要股指收 盘涨跌不一，英国富时100指数上涨0.58%，德国D ...

Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]

Core Viewpoint - The medical device sector experienced a rise of 0.54% on January 21, with N Aisheren leading the gains, while the Shanghai Composite Index increased by 0.08% and the Shenzhen Component Index rose by 0.7% [1] Group 1: Stock Performance - N Aisheren (code: 920050) closed at 44.04, with a remarkable increase of 175.59% and a trading volume of 141,600 shares [1] - Tianzhihang (code: 688277) saw a rise of 12.38%, closing at 23.88 with a trading volume of 376,500 shares [1] - Xishan Technology (code: 688576) increased by 11.18%, closing at 76.80 with a trading volume of 34,000 shares [1] - Kangzhong Medical (code: 688607) rose by 10.91%, closing at 59.67 with a trading volume of 76,200 shares [1] - Shuoshi Biological (code: 6658889) increased by 9.74%, closing at 84.84 with a trading volume of 70,300 shares [1] Group 2: Capital Flow - The medical device sector saw a net inflow of 300 million yuan from institutional investors, while retail investors experienced a net outflow of 430 million yuan [2] - Major stocks like Sainuo Medical (code: 688108) had a net inflow of 69.18 million yuan from institutional investors, but a net outflow of 44.76 million yuan from retail investors [3] - LePu Medical (code: 300003) had a net inflow of 48.54 million yuan from institutional investors, with a slight net inflow of 0.52 million yuan from retail investors [3]

Summary of Key Points from Conference Call Records Industry Overview - The AI computing sector is currently experiencing a bottoming phase, with expectations of gradual recovery starting in February and reaching a peak in March and April, with an overall increase potentially exceeding 50% [1][2][6] - AI applications are expected to see short-term adjustments but maintain a positive long-term outlook, with a new wave of growth anticipated during the March earnings release period [1][2][6] Core Insights and Arguments - The decline in annual report forecasts should not be overly concerning, as it reflects strong industry demand rather than a lack of it. For instance, Shenghong Technology's lower forecast was attributed to raw material shortages and capacity constraints [1][4][7] - Current valuations are estimated at 15-20 times for 2026 and 7-10 times for 2027, suggesting that market dips present good buying opportunities [4][15][17] - The domestic computing industry is supported by strong supply and demand dynamics, with significant growth expected this year, particularly in cabinet-level and superpoint solutions [1][5][9] Investment Opportunities - Investors should focus on sectors where AI applications are gaining traction, such as customer service, video, and finance, which have begun to scale up [1][10][19] - Companies with technological barriers and core competitiveness, such as Alibaba and Tencent, are highlighted as potential investment targets due to their strong growth prospects [11][19] - The optical cable industry is experiencing increased demand, with China Telecom planning to procure over 78 million kilometers of new optical cables, indicating a tightening supply-demand relationship [3][22][23] Additional Important Insights - The AI computing sector is expected to see significant growth opportunities in the coming months, particularly in March, with core companies potentially doubling in value [14][18] - The light-asset model of companies like Xuchuang and Xinyi Sheng is expected to outperform heavier asset models due to their ability to increase shipment volumes even during large-scale expansions [16][17] - The optical cable market is projected to continue its upward trend in pricing due to increased demand from AI data center construction, with companies like Hengtong, Zhongtian, and Changfei being well-positioned [3][22][23] Conclusion - The overall sentiment towards the AI computing and application sectors remains optimistic, with significant growth expected in the near future. Investors are encouraged to strategically position themselves in these sectors to capitalize on upcoming opportunities.

Market News - The US stock market experienced a significant decline, with the Dow Jones falling by 1.76%, the S&P 500 dropping by 2.06%, marking the largest single-day drop since October of the previous year, and the Nasdaq Composite decreasing by 2.39% [1] - The 10-year US Treasury yield rose by 6.76 basis points to 4.2906%, while the 30-year yield increased by 7.92 basis points to 4.9158%, reaching a new high since September of the previous year [1] - The Danish pension fund "AkademikerPension" plans to sell all its US Treasury holdings by the end of January due to perceived credit risks associated with Trump's policies [1] Industry Insights - The Beijing International Commercial Space Exhibition will take place from January 23 to 25, 2026, featuring over 300 exhibitors and covering key areas such as rocket systems, satellite manufacturing, and space applications, with an expected procurement and investment total exceeding 1.2 trillion yuan [3] - The satellite communication industry is projected to reach between 200 billion to 400 billion yuan by 2030, with an annual growth rate of 10%-28%, driven by technological advancements and cost reductions [4] - The global brain-computer interface market is expected to reach $40 billion by 2030 and $145 billion by 2040, with significant potential in treating neurological disorders [6] - The National Healthcare Security Administration has issued guidelines for pricing medical services related to robotic and remote surgeries, aiming to enhance the accessibility of quality medical resources [7] Investment Opportunities - Key stocks in the satellite communication sector include Yinbang Co., Chunhui Zhikong, and Tianyin Electromechanical [4] - In the brain-computer interface space, potential investment targets include Zhongke Information, Guanhao Biological, and Aipeng Medical [6] - Companies involved in robotic surgery and remote surgical assistance include Chutian Technology, Dafu Technology, and Tianzhihang [7] Stock Alerts - A shareholder of Aolian Electronics plans to reduce their stake by up to 3% through various trading methods [8] - Desheng Technology's controlling shareholder intends to sell up to 1% of the company's shares due to personal financial needs [8] - Other companies such as Lanfeng Biochemical and Zhixin Precision are also planning to reduce their shareholdings by up to 3% [8]

Economic Overview - The GDP growth for Q4 2025 is reported at 4.5%, matching expectations but down from 4.8% in the previous quarter. December retail sales growth is at 0.9%, below the expected 1.5% and previous 1.3% [12][12] - Fixed asset investment shows a cumulative year-on-year decline of 3.8%, worse than the expected decline of 2.4% and previous 2.6%. Real estate development investment has a cumulative decline of 17.2% compared to the previous 15.9% [12][12] - Industrial value-added growth for December is reported at 5.2%, exceeding the expected 4.9% and previous 4.8% [12][12] Key Changes in Economic Structure - Three significant changes are identified: improvement in service consumption, easing of the "crowding out effect" from debt reduction, and recovery in new economic sectors [12][12] - The shift in consumption policies from goods to services is noted, with service retail growth increasing while traditional retail indicators decline [12][12] - Investment slowdown is attributed to intensified corporate debt repayment policies, which ultimately benefit cash flow recovery for companies [12][12] Sector Performance - The electric grid equipment sector shows a significant increase of 60.88% over the past six months, with a daily increase of 7.01% [1] - The digital media sector has seen a decline of 4.34% yesterday, with a 21.93% increase over the past month [1] - The hotel and catering industry has increased by 3.87% yesterday and 20.46% over the past six months, indicating resilience in service consumption [1] Investment Opportunities - The report highlights potential investment opportunities in sectors benefiting from service consumption recovery and easing debt repayment pressures [12][12] - Companies in the PCB drilling needle industry are noted for their growth potential, driven by increasing demand in emerging markets [20][20] - The report suggests focusing on companies with strong cash flow recovery and those positioned in high-growth sectors such as healthcare and technology [12][12][20]

Core Viewpoint - Strong Brain Technology is set to achieve its first profitable year in 2025, with significant revenue contributions from products aimed at the mass consumer market [4][17]. Group 1: Company Overview - Strong Brain Technology, founded by Han Bicheng in 2015, operates offices in Hangzhou, Shenzhen, and the US (Boston and Austin), with a peak employee count of around 300-400 [9]. - The company has recently gained attention due to favorable market conditions, including the influence of Musk and supportive domestic policies, positioning it prominently among the "Hangzhou Six Dragons" [9][31]. - In January 2026, Strong Brain completed a record-breaking financing round of 2 billion yuan, the largest single financing in the "Six Dragons" group, and has secretly applied for an IPO in Hong Kong [10][20]. Group 2: Product Lines and Market Strategy - Strong Brain has three main product lines: intelligent bionic series (prosthetics), intelligent health series (sleep aids, attention training), and intelligent education [20]. - The company’s bionic hands can be priced at tens of thousands of dollars in overseas markets, contributing nearly half of its total revenue, while domestic products are offered at significantly lower prices to accommodate local purchasing power [23]. - The company’s consumer products include a wearable brainwave device and a smart sleep aid, which have gained popularity despite some controversy regarding their effectiveness and privacy concerns [24][26]. Group 3: Industry Context and Competition - The brain-computer interface (BCI) sector is experiencing rapid growth, with 16 financing events in 2025 totaling 983 million yuan, a nearly fourfold increase from 2024 [16]. - Strong Brain's approach focuses on non-invasive technology, which is seen as a more practical and commercially viable path compared to invasive methods [20]. - The global competition in the BCI field is intensifying, with significant developments from companies like Neuralink, which is expected to start large-scale production of BCI devices in 2026 [34][35]. Group 4: Future Aspirations and Challenges - Strong Brain aims to help 1 million disabled individuals regain mobility and reintegrate into society within the next five to ten years, supported by its recent funding for core technology development and product scaling [31]. - Despite the promising outlook, the BCI industry faces challenges such as technological breakthroughs, ethical reviews, and the construction of commercial closed loops, which could hinder progress [36].

智通财经APP获悉，华福证券发布研报称，近期，超声脑机接口公司MergeLabs完成约2.5亿美元种子轮 融资，此次融资由OpenAI领投。不同于主流脑机接口技术，MergeLabs聚焦超声为核心的非侵入或极 低侵入式路线。MergeLabs的超声路线试图在非侵入式(安全但分辨率有限)与植入式(信号清晰但有外科 风险、伦理监管问题)之间寻找平衡，其超声的深部穿透能力与"软接口"设想具备独特潜力。但该技术 目前仍处于实验室研究阶段。 当前脑机接口主要分为非侵入式、植入式及低侵入式三类路径，MergeLabs的超声路线试图在非侵入式 (安全但分辨率有限)与植入式(信号清晰但有外科风险、伦理监管问题)之间寻找平衡，其超声的深部穿 透能力与"软接口"设想具备独特潜力。但该技术目前仍处于实验室研究阶段，面临分子信号稳定性、超 声空间分辨率与安全窗口、低信噪比下神经状态反推等多重未解决的难题，复杂性不亚于植入式系统。 "十五五"重点赛道，脑机接口市场规模有望快速增长 根据Precedence research，2024年全球脑机接口市场规模约为26.2亿美元，预计2025年将达到29.4亿美 元，到2034年有望增长至1 ...